Pharmacokinetics and the most suitable regimen of panipenem/beta mipron in critically ill patients receiving continuous renal replacement therapy : a pilot study
スポンサーリンク
概要
- 論文の詳細を見る
Critically ill patients are often complicated with acute renal failure induced by severe infection or sepsis. The patients need administration of broad-spectrum antibiotics as well continuous renal replacement therapy (CRRT). However, there is no uniform pharmacokinetics of antibiotics during the CRRT because CRRT is performed with the various combinations of dialysate flows (QD) and ultrafiltrate flows (QF). The aims of this study were to estimate the pharmacokinetics of panipenem/betamipron (PAPM/BP) and to determine the appropriate treatment regimens for PAPM/BP in critically ill patients undergoing CRRT. In patients with CRRT, the PAPM total clearance (PAPM CLtot) was calculated as the sum of PAPM clearance dependent on the living body and CRRT and shown as follow: PAPM CLtot (ml/min) = (1.2 CLcre+ 66.5) + 0.86 (QD+QF) where CLcre is creatinine clearance. Pharmacokinetic values of PAPM were measured in 4 patients with CRRT. According to these results, the most appropriate treatment regimen regarding PAPM CLtot (ml/min) showed as follows: {PAPM CLtot < 80} {0.5 g every 12 hr or 1 g every 15 hr} {PAPM CLtot 80-120} {0.5 g every 8 hr or 1 g every 12 hr} {PAPM CLtot 120-160} {0.5 g every 6 hr or 1 g every 8 hr}
- Lippincott Williams & Wilkinsの論文
Lippincott Williams & Wilkins | 論文
- The effects of serotionin and/or noradrenaline reuptake inhibitors on impulsive-like action assessed by the three-choice serial reaction time task : a simple and valid model of impulsive action using rats
- Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, B beta Gly15Cys (Hamamatsu II)
- Spinal Cord Compression by Ligamentum Flavum Hematoma in the Thoracic Spine
- The Administration of Ciprofloxacin During Continuous Renal Replacement Therapy : Pilot Study
- Pharmacokinetics and the most suitable regimen of panipenem/beta mipron in critically ill patients receiving continuous renal replacement therapy : a pilot study